Therapeutics & Diagnostics targeting nf-P2X7
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
21
NCT02587819
Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment
Phase: Phase 1
Role: Lead Sponsor
Start: May 31, 2013
Completion: Apr 30, 2014
Loading map...